Discover

IMDX
Insight Molecular Diagnostics Inc.
4.42
1 x 4.39
4 x 4.41
bid
ask
-
0.35
7.34%
01:33 PM
timesize
Ytd-41.07%
1y69.35%
4.33
day range
4.64
2.33
52 week range
8.51
Open4.64Prev Close4.77Low4.33High4.64Mkt Cap142.72M
Vol250.70KAvg Vol248.50KEPS-1.19P/E-3.71Forward P/EN/A
Beta1.79Short RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1050-d Avg5.24200-d Avg5.481yr Est0.00
Income Statement
Total Revenue32.00K
Revenues (USD)32.00K
Cost of Revenue17.00K
Gross Profit15.00K
Operating Expenses4.43M
Research and Development Expense4.95M
Selling, General and Administrative Expense5.39M
Operating Income-4.41M
Interest Expense23.00K
Net Income-4.29M
Net Income Common Stock-4.29M
Net Income Common Stock (USD)-4.29M
Consolidated Income-4.29M
Earnings per Basic Share-0.12
Earnings per Basic Share (USD)-0.12
Earnings per Diluted Share-0.12
Earning Before Interest & Taxes (EBIT)-4.27M
Earning Before Interest & Taxes (USD)-4.27M
Weighted Average Shares34.52M
Weighted Average Shares Diluted34.52M
Balance Sheet
Cash and Equivalents28.93M
Cash and Equivalents (USD)28.93M
Trade and Non-Trade Receivables157.00K
Current Assets30.52M
Property, Plant & Equipment Net8.91M
Total Assets40.43M
Debt Current1.76M
Total Debt3.07M
Current Liabilities12.01M
Debt Non-Current1.31M
Total Liabilities51.12M
Accumulated Retained Earnings (Deficit)-405.05M
Accumulated Other Comprehensive Income71.00K
Shareholders Equity-10.69M
Shareholders Equity (USD)-10.69M
Assets Non-Current9.91M
Total Debt (USD)3.07M
Inventory382.00K
Liabilities Non-Current39.11M
Trade and Non-Trade Payables4.35M
Cash Flow
Depreciation, Amortization & Accretion631.00K
Net Cash Flow from Financing24.70M
Net Cash Flow / Change in Cash & Cash Equivalents16.44M
Capital Expenditure-613.00K
Issuance (Purchase) of Equity Shares26.02M
Issuance (Repayment) of Debt Securities -143.00K
Net Cash Flow from Investing-613.00K
Net Cash Flow from Operations-7.64M
Effect of Exchange Rate Changes on Cash -10.00K
Share Based Compensation647.00K